JW (Cayman) Therapeutics Co. Ltd (HKG:2126)
Hong Kong · Delayed Price · Currency is HKD 5.10
-0.03 (-0.58%)
Sep 11, 2025, 4:08 PM HKT
HKG:2126 Market Cap
HKG:2126 has a market cap or net worth of 2.08 billion as of September 11, 2025. Its market cap has increased by 262.41% in one year.
Market Cap
2.08B
Enterprise Value
1.78B
Revenue
194.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.10
Market Cap Chart
Since November 3, 2020, HKG:2126's market cap has decreased from 8.28B to 2.08B, a decrease of -74.86%. That is a compound annual growth rate of -24.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2025 | 2.08B | 301.60% |
| Dec 31, 2024 | 518.01M | -42.89% |
| Dec 29, 2023 | 907.01M | -47.90% |
| Dec 30, 2022 | 1.74B | -67.36% |
| Dec 31, 2021 | 5.33B | -47.83% |
| Dec 31, 2020 | 10.22B | 23.51% |
| Nov 3, 2020 | 8.28B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 297.05B |
| Hansoh Pharmaceutical Group Company | 231.38B |
| JD Health International | 201.85B |
| Innovent Biologics | 172.13B |
| Sino Biopharmaceutical | 161.14B |
| WuXi Biologics | 159.07B |
| Akeso | 131.26B |
| CSPC Pharmaceutical Group | 131.25B |